Zoe Cadore is considering a run for the Houston-area congressional seat that has come open after the death of Democratic Rep.

A Houston-based pharmaceuticals company filed for Chapter 7 bankruptcy, and its leaders have either resigned or been terminated.

About three months after leaving her post as the FDA’s principal deputy commissioner, Namandjé Bumpus, Ph.D., has found a new ...

SOUTH SAN FRANCISCO, Calif., March 20, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced its business update and financial results for the full year 2024.

Initiated Phase 1 clinical trial evaluating its second-generation oral norovirus vaccine constructs with topline data expected as early as mid-2025 Continues per protocol follow-up for the COVID-19 ...

Recursion Pharmaceuticals appointed former FDA principal deputy commissioner Namandjé Bumpus, PhD, and Elaine Sun, the COO and CFO of Mammoth Biosciences, to its board of directors. CAMP4 Therapeutics ...

The proposed merger would create a new ophthalmic company that combines two FDA-approved technologies: Betaliq's EyeSol ® water-free drug delivery technology for use in glaucoma, and Eyenovia's ...

Combination, if successful, would create a new publicly-listed eye care company combining Betaliq's EyeSol® water-free drug delivery technology for glaucoma with Eyenovia's Optejet® device platform Th ...

Non-executive directors are supposed to provide a company’s management with independent perspectives. Does the experience ...

Thousands of Food and Drug Administration employees are returning to the office to find overflowing parking lots, cramped ...

Curevo has set its sights on competing with GSK’s shingles vaccine dominance by securing $110m and securing a former executive from the UK big pharma to advance its candidate amezosvatein.